Healthcare stocks were edging higher premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) advancing by 0.4%.
Pacira BioSciences' (PCRX) non-opioid pain therapy Exparel is now separately reimbursed by UnitedHealthcare (UNH) across outpatient settings, including hospital outpatient departments and ambulatory surgery centers, the company said. Shares of Pacira BioSciences were up more than 3% pre-bell.